» Articles » PMID: 22260937

Low Levels of 25(OH)D and Insulin-resistance: 2 Unrelated Features or a Cause-effect in PCOS?

Overview
Journal Clin Nutr
Publisher Elsevier
Date 2012 Jan 21
PMID 22260937
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Recent investigations have identified low vitamin D status as a hypothetical mechanism of insulin-resistance in Polycystic Ovary Syndrome (PCOS). Instead, some authors supported the hypothesis that low vitamin D levels and insulin-resistance are 2 unrelated features of body size in PCOS. Hence, we aimed to explore the association of 25-hydroxyvitamin D (25(OH)D) with anthropometric, metabolic and hormonal features in PCOS.

Methods: We assessed the association of low 25(OH)D levels with endocrine parameters, insulin-sensitivity evaluated by hyperinsulinemic euglycemic clamp (HEC) and body composition measured by DEXA in 38 women affected by PCOS.

Results: Low 25(OH)D (25(OH)D < 50 nmo/L) was detected in 37% of the entire cohort of patients. Body Mass Index (BMI), in particular total fat mass (p < 0.001), resulted to be the most predictor factor of 25(OH)D levels whereas Sex Hormone Binding Globulin (SHBG), Free Androgen Index (FAI), glucose uptake and fat free mass were not.

Conclusions: Our data demonstrated that in PCOS low 25(OH)D levels are significantly determined by the degree of adiposity.

Citing Articles

Comparative effects of acupuncture and metformin on insulin sensitivity in overweight/obese and lean women with polycystic ovary syndrome and insulin resistance: a analysis of a randomized trial.

Cao J, Nie G, Dai Z, Shan D, Wei Z Front Med (Lausanne). 2023; 10:1232127.

PMID: 38155665 PMC: 10753002. DOI: 10.3389/fmed.2023.1232127.


A comprehensive review on the impact of calcium and vitamin D insufficiency and allied metabolic disorders in females.

Ahmed A, Saleem M, Saeed F, Afzaal M, Imran A, Akram S Food Sci Nutr. 2023; 11(9):5004-5027.

PMID: 37701195 PMC: 10494632. DOI: 10.1002/fsn3.3519.


Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome.

Lejman-Larysz K, Golara A, Baranowska M, Kozlowski M, Guzik P, Szydlowska I Nutrients. 2023; 15(13).

PMID: 37447279 PMC: 10346142. DOI: 10.3390/nu15132952.


Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features.

Capece U, Moffa S, Improta I, Giuseppe G, Nista E, Cefalo C Nutrients. 2023; 15(1).

PMID: 36615676 PMC: 9824456. DOI: 10.3390/nu15010018.


Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome?.

Barrea L, Verde L, Vetrani C, Savastano S, Colao A, Muscogiuri G Nutrients. 2022; 14(5).

PMID: 35267930 PMC: 8912410. DOI: 10.3390/nu14050955.